While there are other thyroid antibodies that can be measured, TPO levels are considered the most reliable marker for Hashimotos thyroiditis
Finally, IC 025 0.8 for all GLP-1 RAs in primary and false-negative analyses
This corresponds with sustained appetite reduction and improved food choices, as the medication makes high-calorie foods less appealing
Semaglutide 2.4 mg (Wegovy): ~15% body weight loss at 68 weeks in clinical trials Tirzepatide 15 mg (Zepbound): ~21% body weight loss at 72 weeks in clinical trials Real-world data shows lower results: Cleveland Clinic research from 2025 found average weight loss of 7.7% with semaglutide and 12.4% with tirzepatide at one year in routine clinical practice
Data were re-analysed according to the per-protocol definitions and found only minor changes to AUC 0 and C max , with no effect on the conclusions
Sun Y, Aliyari SR, Parvatiyar K, Wang L, Zhen A, Sun W